Sabra Health Care REIT, Inc. (SBRA) Stock: Price, Forecast & Analyst Target
Sabra Health Care REIT, Inc. (SBRA) — MoonshotScore 63/100 (Fair band), calculated Nov 18, 2026. Price $20.46 (-0.78%), as of the Nov 19, 2026 trading session; market cap $5.36B. Expected results Feb 11, 2027.
Educational signal · not a buy or sell recommendation · How to read this
Sabra Health Care REIT, Inc. · SBRA · NASDAQ · Real Estate · REIT - Healthcare Facilities
Research dated 2026-09-13 (results through Q2 FY2026; Q3 FY2026 not covered): Sabra Health Care REIT acquires and finances real estate for healthcare operators, collecting rent and lease revenue. Healthcare REIT income stability depends on tenant credit quality and occupancy rates; the decisive question is whether tenant defaults are rising and whether occupancy recovery is sustainable.
Price as of Nov 19, 2026
Key Statistics
MoonshotScore v2 · Sabra Health Care REIT (SBRA)
FairWhy this rating? Method, drivers & history
Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.
- Business Quality — Is this a genuinely good business?
- Financial Safety — Could this blow up on me?
- Valuation — Am I paying a fair price?
- Growth Durability — Is the growth real and likely to last?
- Momentum — Is the market already moving on this?
A full valuation, though growth is only middling; the market is already moving on it. Business Quality: Solid; Financial Safety: Okay; Valuation: Full; Growth Durability: Flat; Momentum: Rising.
- quarterly revenue $250M (Q3 FY2026, quarter ended Sep 30, 2026)
- EPS beat 2 of the last 8 reports
- Altman Z 0.92 · Piotroski F 6
Helping: positive momentum
What has the MoonshotScore done over time?
| Recorded | Score | Band |
|---|---|---|
| 64 | Fair | |
| 64 | Fair | |
| 64 | Fair | |
| 64 | Fair | |
| 63 | Fair | |
| 63 | Fair |
Daily score refresh is delayed. This is the last recorded calculation.
Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.
Computed · How the MoonshotScore is computed →
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $20.46 | |
| Change on the day | -0.78% | |
| 52-week range | $17.54–$22.77 | |
| Market capitalisation | $5.36B | — |
| Price / earnings (trailing) | 72.32 | |
| Shares traded on the day | 3.20M | |
| Beta (volatility vs the S&P 500) | 0.64 |
Price & events
Triangles mark reported quarters on the line: pointing up is above the recorded estimate, down is below, a diamond means no estimate on file. Numbers key to the dated list. Point at or tab to any week for its close.
Events behind the price
- · Earnings results · below the recorded estimate
- · Earnings results · below the recorded estimate
- · Earnings results · below the recorded estimate
- · Earnings results · below the recorded estimate
Results dates follow the earnings feed; call dates follow the transcript provider. Nearby dates do not establish that an event caused a price move.
Upcoming events
How to read these dates
Estimated dates can change.
Other perspectives
Council score for Sabra Health Care REIT (SBRA): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
5-Factor Breakdown
Legends Council
6 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Nov 15, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Sep 10, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is Sabra Health Care REIT (SBRA), and what does it report?
Short answer · as of
Sabra's business model is straightforward: own healthcare property, lease it to operators, collect rent as revenue.
Research dated 2026-09-13 (results through Q2 FY2026; Q3 FY2026 not covered).
Profitability is a function of rent collection and debt service; the company distributes most earnings as dividends to shareholders. Revenue is largely contractual and predictable; volatility comes from tenant bankruptcies, lease renegotiations, and capex needs to maintain occupied properties. Real estate value and credit quality of tenants are the two pillars of sustainability.
What do the latest results show for Sabra Health Care REIT (SBRA)?
Short answer · as of
The most recent reported quarter, Q3 FY2026, carried revenue of $250M.
Research dated 2026-09-13 (results through Q2 FY2026; Q3 FY2026 not covered).
Recent quarters showed revenue growing steadily while net income fell, driven by operating losses that hint at elevated capex or tenant-related write-downs. Cash flow from operations was positive but modestly, a sign that the company is managing cash tightly. Dividend guidance was raised, a statement that management sees future cash generation improving; if they're wrong, dividend cuts will follow within quarters.
Where is operating spending going?
Revenue alongside research and development, selling, general and administrative expenses, and the FMP standardized operating result.
| Period end | Revenue | R&D | SG&A | FMP standardized operating result |
|---|---|---|---|---|
| Sep 30, 2026 | Not available | Not available | Not available | Not available |
| Jun 30, 2026 | Not available | Not available | Not available | Not available |
| Mar 31, 2026 | Not available | Not available | Not available | Not available |
| Dec 31, 2025 | Not available | Not available | Not available | Not available |
How to read these figures
Amounts are in US dollars. The operating result is Financial Modeling Prep’s standardized figure, so it can differ from the operating line in the company’s filing. It is not net income or cash flow.
Did results meet expectations?
Reported earnings and revenue alongside the estimates recorded by the provider.
- Latest report · revenue
- $249.56M Nov 2, 2026
- Latest report · revenue estimate
- $236.64M Nov 2, 2026
- Latest report · revenue vs estimate
- Above estimate Nov 2, 2026
- Latest report · EPS vs estimate
- Below estimate Nov 2, 2026
| Report date | Revenue · reported | Revenue · estimate | EPS · reported | EPS · estimate |
|---|---|---|---|---|
| Nov 2, 2026 | $249.56M | $236.64M | $0.1100 | $0.1637 |
| Aug 3, 2026 | $235.87M | $219.39M | −$0.1000 | $0.1711 |
| Apr 29, 2026 | $221.75M | $209.20M | $0.1600 | $0.1667 |
| Feb 12, 2026 | $211.90M | $197.97M | $0.1100 | $0.1700 |
How to read these figures
Dates are when results were reported, not quarter ends. Amounts are in US dollars; EPS is per share. The source does not say whether EPS is basic, diluted or adjusted, so it can differ from the EPS in the income statement.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q3 FY2026 | $250M | $29M | $0.11 (diluted) |
| Q2 FY2026 | $236M | -$25M | -$0.10 (diluted) |
| Q1 FY2026 | $222M | $41M | $0.16 (diluted) |
| Q4 FY2025 | $212M | $27M | $0.11 (diluted) |
What are the financial strengths and risks for Sabra Health Care REIT (SBRA)?
Short answer
Cash and short-term investments were $0.00 at the Sep 30, 2026 balance-sheet date. This figure does not establish a cash runway.
Research dated 2026-09-13 (results through Q2 FY2026; Q3 FY2026 not covered).
Debt is moderate relative to assets but the quick ratio is extraordinarily high, an artifact of how REITs report current liabilities. Net debt-to-market-cap is reasonable; the REIT is not overleveraged. The real risk is tenant credit weakness; if tenants default on rent or exit leases early, occupancy gaps will shrink revenue without cutting costs proportionally.
Data-derived red flags
- Financial-distress signal — its Altman Z-Score of 0.92 sits in the distress zone (elevated bankruptcy risk).
- Inconsistent delivery — missed Wall Street EPS estimates in 6 of the last 8 reported quarters.
- Rich valuation — a P/E of 72.32 runs well above the Real Estate sector’s ~33.30x, leaving little room for a miss.
What should you watch next at Sabra Health Care REIT (SBRA)?
Short answer · as of
The next earnings report is expected on Feb 11, 2027.
Research dated 2026-09-13 (results through Q2 FY2026; Q3 FY2026 not covered).
Monitor occupancy rates and rent collection data in quarterly calls; any deterioration signals tenant stress. Watch for lease renegotiations or capex surprises; if the company must make concessions to retain tenants, cash flow pressure will mount. Track whether dividend coverage (cash flow divided by dividend) remains above unity; a shortfall would force dividend cuts or capital raises.
What the records here don't tell us
- No forward revenue or earnings estimate is on file.
Checked against the records this page reads, on the dates shown above.
How does Sabra Health Care REIT compare with its peers?
Short answer
Sabra Health Care REIT's score ranks tied for 9th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.
Research dated 2026-09-13 (results through Q2 FY2026; Q3 FY2026 not covered).
Sabra competes with larger, more diversified healthcare REITs (Welltower, LTC Properties) and with debt capital providers to healthcare operators. Sabra's smaller scale means less diversification across geographies and tenant types; a regional healthcare downturn or a major tenant bankruptcy poses disproportionate risk. Larger peers can absorb these shocks more easily.
| Company | Price | Market value | Score |
|---|---|---|---|
| $24.87 Nov 19, 2026 | $4.13B | 99 5-pillar Nov 18, 2026 | |
| $37.02 Nov 19, 2026 | $9.54B | 92 5-pillar Nov 18, 2026 | |
| $45.92 Nov 19, 2026 | $14.6B | 92 5-pillar Nov 18, 2026 | |
| $61.39 Nov 19, 2026 | $3.01B | 91 5-pillar Nov 18, 2026 | |
| $330.99 Nov 18, 2026 | $61.8B | 88 5-pillar Nov 18, 2026 | |
| $12.16 Nov 19, 2026 | $687M | 81 5-pillar Nov 18, 2026 | |
| $44.51 Nov 17, 2026 | $2.40B | 79 5-pillar Nov 18, 2026 | |
| $40.39 Nov 19, 2026 | $5.71B | 77 5-pillar Nov 18, 2026 | |
| Sabra Health Care REIT (SBRA) — this page | $20.46 | $5.36B | 63 |
| $28.84 Nov 19, 2026 | $4.75B | 63 5-pillar Nov 18, 2026 | |
| $247.25 Nov 18, 2026 | $181B | 63 5-pillar Nov 18, 2026 | |
| $58.55 Nov 18, 2026 | $13.6B | 60 5-pillar Nov 18, 2026 | |
| $87.00 Nov 19, 2026 | $46.0B | 60 5-pillar Nov 18, 2026 |
Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.
The records behind this page
Analyst targets & estimates
What analysts have on file
- Price target, low to high
- $20.00 – $23.00
- Consensus target
- $21.83
- Median target
- $22.00
Consensus record · Captured .
Measured against a quoted price of $20.46 (as of Nov 19, 2026).
Insider activity
Form 4 records via FMP · Of the newest 100 records, those within the last 180 days, newest dated Nov 11, 2026
- Transactions
- 30
- Identified insiders
- 10
- Purchases
- 0
- Sales
- 2
- Other transactions
- 28
Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held SBRA in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported SBRA in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
What has been published about Sabra Health Care REIT (SBRA)?
Common Questions About SBRA (Real Estate)
Research dated 2026-09-13 (results through Q2 FY2026; Q3 FY2026 not covered); the full attribution is under Sources. The last 2 questions are answered from this page's own dated data, not from the research.
Are tenant defaults rising or falling?
The brief does not disclose specific tenant credit metrics or default counts, a material omission for a REIT. Quarterly calls and supplemental disclosures in earnings releases would show occupancy trends and problem-lease data; public data provided here does not confirm direction.
Is the dividend sustainable at current levels?
Operating cash flow has historically covered the dividend, but recent performance shows deterioration with weakened cash generation. This raises questions about dividend sustainability. If operating cash flow remains under pressure, dividend reductions could follow; management typically signals financial strain through guidance changes and messaging shifts before taking such action. Investors should monitor quarterly earnings calls and updated forecasts for warnings of cash flow stress.
How much capex is required to keep tenants in occupied space?
The brief shows zero capex in most recent quarters, which is unusual for a REIT; newer properties typically require maintenance capex or tenant-improvement capex to retain operators. The recent quarter showed modest capex, suggesting either the portfolio is mature or management is deferring maintenance to prop up cash flow.
What would trigger a dividend cut?
A sharp occupancy decline, a material tenant default, or sustained negative cash flow would all force management to reduce distributions. The company has little room to absorb shocks; even a single large tenant bankruptcy would crimp cash flow enough to pressure the dividend.
What is the SBRA stock price today?
The last price recorded for Sabra Health Care REIT, Inc. (SBRA), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What is the SBRA price target?
The analyst consensus price target for Sabra Health Care REIT, Inc. (SBRA), with its range and the date it was captured from FMP, is listed under Analyst targets & estimates on this page. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.
Research written by Claude (claude-haiku-4-5) on 2026-09-13. AI-authored analysis; source dates are listed under Sources. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 43 figures on this page — 37 from Financial Modeling Prep (FMP), 3 with no recorded source, 2 computed by us, formula shown in the register and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com